dc.contributor.author | Bilici, Ahmet | |
dc.contributor.author | Selçukbiricik, Fatih | |
dc.contributor.author | Rzazade, Rashad | |
dc.contributor.author | Ölmez, Ömer Fatih | |
dc.contributor.author | Çağlar, Hale Başak | |
dc.contributor.author | Yıldız, Özcan | |
dc.date.accessioned | 10.07.201910:49:13 | |
dc.date.accessioned | 2019-07-10T20:01:33Z | |
dc.date.available | 10.07.201910:49:13 | |
dc.date.available | 2019-07-10T20:01:33Z | |
dc.date.issued | 2017 | en_US |
dc.identifier.citation | Bilici, A., Selçukbiricik, F., Rzazade, R.,Ölmez, Ö. F., Çağlar, H. B. ve Yıldız, Ö. (2017). Outcomes of patients with oligometastatic non-small cell lung cancer who were treated with radical treatment. Journal of Thoracic Oncology içinde (S2092-S2092. ss.). | en_Us |
dc.identifier.issn | 1556-0864 | |
dc.identifier.issn | 1556-1380 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/3341 | |
dc.description.abstract | ... | en_Us |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Aggressive Treatment | en_US |
dc.subject | Non-Small Cell Lung Cancer | en_US |
dc.subject | Oligometastatic Disease | en_US |
dc.title | Outcomes of patients with oligometastatic non-small cell lung cancer who were treated with radical treatment | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | Journal of Thoracic Oncology | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı | en_US |
dc.authorid | 0000-0001-7934-7039 | en_US |
dc.identifier.volume | 12 | en_US |
dc.identifier.issue | 11 | en_US |
dc.identifier.startpage | S2092 | en_US |
dc.identifier.endpage | S2092 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.wosquality | Q1 | en_US |